Infection with multiple genetically distinct strains of pathogen is common and can lead to positive (complementation) or negative (competitive) within-host interactions. These interactions can alter aspects of the disease process and help shape pathogen evolution. Infection of the host with multiple strains of cytomegalovirus (CMV) occurs frequently in humans and mice. Profound, NK-cell-mediated (apparent) competition has been identified in C57BL/6 mice, and prevented the replication and shedding of certain co-infecting CMV strains. However, the frequency of such strong competition has not been established. Other within-host interactions such as complementation or alternative forms of competition remain possible. Moreover, high rates of recombination in both human CMV and murine CMV (MCMV) suggest prolonged periods of viral co-replication, rather than strong competitive suppression. An established model was employed to investigate the different possible outcomes of multi-strain infection in other mouse strains. In this study, co-replication of up to four strains of MCMV in the spleen, liver and salivary glands was observed in both MCMV-susceptible and MCMV-resistant mice. In the absence of apparent competition, no other forms of competition were unmasked. In addition, no evidence of complementation between viral strains was observed. Importantly, co-replication of MCMV strains was apparent for up to 90 days in the salivary glands. These data indicated that competition was not the default outcome of multi-strain CMV infection. Prolonged, essentially neutral, co-replication may be the norm, allowing for multi-strain transmission and prolonged opportunities for recombination.
INTRODUCTION
Infectious diseases are frequently the result of concurrent or sequential infection with multiple genetically distinct pathogen strains. Definitive evidence of multi-strain infection has been documented for .50 human pathogens, including bacteria, protozoa, helminths, fungi and viruses (Balmer & Tanner, 2011) . Multi-strain infection appears to be particularly common amongst the herpesviruses, and has been demonstrated for herpes simplex virus (HSV) type 1 (Roest et al., 2004) and type 2 (Roest et al., 2006) [human herpesvirus (HHV)-1 and -2], varicella zoster virus (HHV-3) (Quinlivan & Breuer, 2006) , Epstein-Barr virus (HHV-4) (van Baarle et al., 1999) , human cytomegalovirus (HCMV; HHV-5) (Drew et al., 1984; Spector et al., 1984) and Kaposi's sarcoma-associated herpesvirus (HHV-8) (Beyari et al., 2003) .
HCMV, a member of the beta herpesvirus subfamily, is a large, enveloped ssDNA virus with a worldwide prevalence, dependent on socioeconomic status and geographical location, of 55-100 %. HCMV infection is life-long, but is generally asymptomatic in the immunocompetent host. In the immunocompromised individual, HCMV can cause significant morbidity and mortality. Despite the advent of highly effective anti-retroviral therapies, human immunodeficiency virus/AIDS patients remain at risk of HCMVinduced retinitis, uveitis and vitritis (Scholz et al., 2003) .
HCMV has become the most common cause of intrauterine viral infection in industrialized nations and causes congenital abnormalities, such as sensorineural hearing loss and mental retardation (Ahlfors et al., 1999) . For solid-organ and bone marrow allograft recipients, HCMV remains a major opportunistic pathogen (De Keyzer et al., 2011; Streblow et al., 2007) .
Whilst multiple HCMV infections have been demonstrated in immunocompetent patients (Chandler et al., 1987; Huang et al., 1980) , most studies have focused on the immunocompromised. Multi-strain infection has been demonstrated in all the HCMV at-risk patient groups, including patients with leukaemia and lymphoma (Coaquette et al., 2004; Eizuru et al., 1990) , congenitally infected neonates (AravBoger et al., 2002) , solid-organ allograft recipients (Manuel et al., 2009 ) and bone marrow transplant recipients (Fries et al., 1994) . The effects of multi-strain cytomegalovirus (CMV) infection on disease outcome and viral evolution in these patients groups are, however, not fully understood. Whilst many clinical studies have indicated a link between multi-strain HCMV infection and enhanced disease, elevated viral loads or reduced organ survival in transplant recipients (Coaquette et al., 2004; Grundy et al., 1988; Humar et al., 2003; Ishibashi et al., 2007; Puchhammer-Stöckl et al., 2006; Sarcinella et al., 2002) , the mechanism behind this enhanced disease remains unknown.
Theoretical studies suggest individual pathogen strains can participate in either positive (complementary) or negative (competitive) interactions when co-infecting the same host (Read & Taylor, 2001; West et al., 2007) . Complementation between strains of HCMV has intuitive appeal as an explanation for enhanced disease seen in multi-straininfected patients. Whilst complementation been strains of murine CMV (MCMV) has been demonstrated in the mouse model (Cardin et al., 2009; Cicin-Sain et al., 2005; Saederup et al., 2001) , these studies were not designed to detect elevated disease. Moreover they demonstrated trans-complementation between parental virus and otherwise identical gene deletion mutants. Complementation between naturally circulating strains of CMV has not been demonstrated.
Competition could also explain enhanced disease in multistrain-infected patients, if this led to strain replacement or preferential replication of more virulent viral strains. The presumption being that these strains would do more damage to the host than a mix of virulent and less virulent strains. A previous study of multi-strain MCMV infection in C57BL/6 (B6) mice demonstrated profound immunemediated competition between viral strains (McWhorter et al., 2013) . This immune-mediated competition (also known as apparent competition) led to selective replication and shedding of the more virulent viral strains. However, this did not result in an obvious increase in disease. Moreover, in other model systems, competition is frequently experienced by both low and high virulence stains. In these instances, competition can lead to reduced disease due to competitive suppression of the more virulent strain (reviewed by Read & Taylor, 2001 ).
Apparent competition in B6 mice was due to strain-specific recognition of MCMV by NK-cells. Specificity was supplied by Ly49H, an NK-cell activation receptor, which is capable of differential recognition of allelic variants of its cognate ligand, virally encoded m157 (McWhorter et al., 2013) . The Ly49 family encodes both inhibitory and activatory receptors, which like m157 may also be allelic. The Ly49 family is also polygenic and variation in this potential receptor/ligand pair has complex effects on the control of viral replication. During acute single-strain infection Ly49H-mediated immunosurveillance leads to reduced viral replication (Scalzo et al., 1990) . Paradoxically, this same interaction leads to enhanced persistence of the virus in the salivary glands of infected mice (Andrews et al., 2010) . As some m157 alleles target Ly49 inhibitory receptors, this gene can also aid acute viral replication (Forbes et al., 2014) . Therefore, during single-strain infection m157 can have negative, positive or neutral (when it engages no Ly49 family member) effects on viral replication. In contrast, during multi-strain infection, Ly49H is capable of mediating competition and selecting for preferential transmission of more virulent viral strains. Therefore, the outcome of singleand multi-strain infection can be profoundly altered by allelic variation within a single viral gene.
Given the complexity of host and viral genetics, the breadth of outcomes possible following multi-strain infection requires empirical testing. For instance, is competition the default outcome of multi-strain infection or can complementation also occur? Does robust apparent competition mask more subtle within-host interactions, such as resource-mediated competition? Does the signature of recombination present in both HCMV and MCMV (Faure-Della Corte et al., 2010; Smith et al., 2013) suggest prolong periods of co-replication rather than competition? In this study we sought to extend our previous work (McWhorter et al., 2013) to determine if competition could be observed in other mouse strains; if complementation leading to enhanced viral loads was possible in multi-strain infection; and if, in the absence of apparent competition, viral strains were capable of longterm co-replication or do other forms of competition become detectable. To perform these studies we used two strains of inbred mice: MCMV-resistant CBA mice and MCMV-susceptible BALB/c mice. We found no evidence in either mouse strain of competition or complementation. Rather, both mouse strains supported long-term coreplication of all inoculated viral strains. This co-replication was without obvious cost to either the host or the coinfecting strains. In all mice, all MCMV strains replicated in the spleen and liver, and disseminated to and replicated within the salivary glands, indicating that co-shedding of virus was likely. These data indicated that neutral coinfection was possible for MCMV, and that multiple strains of MCMV were likely to be shed and transmitted to new hosts from the infected salivary glands.
RESULTS

Multi-strain infection of MCMV-resistant CBA mice
We have shown previously that multi-strain infection can lead to NK-cell-mediated within-host competition between viral strains in MCMV-resistant B6 mice (McWhorter et al., 2013) . In this study, we employed another MCMVresistant mouse strain, CBA. Mechanistically, the resistance of CBA mice to MCMV remains unknown, although both H-2 (H-2 k )-and non-H2-linked genes, but not Ly49H, are important (reviewed by Shellam et al., 2007) . In these studies, we define complementation as a significantly higher mean viral load in multi-strain-infected mice than that seen in every, control, single-strain-infected cohort.
CBA mice were infected intraperitoneally with 1610 4 p.f.u. C4A, C4B, C4C or C4D, or a total of 1610 4 p.f.u. comprising an equal mix of all four strains. Viral titres in infected mice were assessed in the spleen and liver at day 3, and in the salivary glands at day 18 post-infection (p.i.). All four strains of MCMV were capable of replication within the spleen and liver (Fig. 1a) of CBA mice. There was no evidence of complementation between the viral strains leading to enhanced total viral loads in multi-strain-infected mice. Whilst viral titres were higher in the liver of multistrain-infected mice compared with C4A-infected mice, they were not higher than those seen in the other single-straininfected cohorts. Likewise, we noted no evidence of complementation in the salivary glands of multi-straininfected mice (Fig. 1b) .
Quantitative real-time (qRT)-PCR was used to identify the composition of strains infecting each organ (Fig. 2) . In multi-strain-infected CBA mice, all four strains of MCMV were capable of replication in the spleen (Fig. 2a) , liver ( Fig. 2b ) and salivary gland (Fig. 2c) . Whilst there were subtle differences between DNA copy loads in single-versus multi-strain infection, there were no overt effects of multistrain infection on the capacity of individual strains to replicate in CBA mice. Where strains showed higher DNA copy numbers than others, such as C4B compared with C4A or C4C in the spleen, the elevated levels of these viruses were not at the expense of the co-infecting strains. Indeed, DNA copy loads for each strain were similar in single-and multistrain-infected mice.
Multi-strain infection in MCMV-susceptible BALB/c mice
We next assessed the outcome of multi-strain infection in MCMV-susceptible mice. BALB/c mice mount a poor NKcell response to MCMV infection, exhibit high viral loads in affected tissues and have a lower LD 50 than most other inbred strains of mice (Allan & Shellam, 1984; Bancroft et al., 1981) . Experiments were as described for CBA mice. During acute infection, all four C4 strains of MCMV were capable of replication in the spleen and liver of BALB/c mice ( Fig. 3a) . As with CBA mice, we detected no evidence of complementation in multi-strain-infected mice. Titres of virus in the livers and spleen of multi-strain-infected mice were only significantly higher (P,0.01) than those seen in C4D-infected mice, but not in the other singlestrain-infected cohorts. Similarly, we saw no evidence of complementation in the salivary glands of multi-straininfected BALB/c mice (Fig. 3b ).
We next assessed individual viral DNA loads in the spleen (Fig. 4a) , liver ( Fig. 4b ) and salivary glands ( Fig. 4c ) of multi-strain-infected BALB/c mice using strain-specific qRT-PCR. As a control, viral DNA levels were also assessed in single-strain-infected mice (Fig. 4) . As with CBA mice, we saw subtle differences in the DNA copy load for individual MCMV strains in multi-strain-infected mice; however, elevated replication of any one strain was not at the expense of the other MCMV strains. Statistical analysis was performed as described in Methods, *P,0.05, **P,0.01, n55 mice per group. The x-axis is set at the limit of detection.
Effects of multi-strain infection on morbidity
MCMV expresses a vast array of genes that, depending on the genetics of the virus and the host, either enhance or suppress host cellular responses. We reasoned that the presence of multiple allelic variants of these genes in a mixed infection could potentially elevate (or reduce) immunopathology, independent of viral loads. As markers of morbidity, we assessed hepatitis [serum alanine aminotransferase (ALT) levels] and weight loss in MCMVinfected mice at day 3 p.i. Individual strains of MCMV differed in their capacity to cause weight loss and hepatitis; however, we noted no evidence of enhanced (or decreased) morbidity in CBA or BALB/c mice infected with multiple strains of MCMV (Fig. 5) . No correlation was seen in this study between weight loss and viral titres in either the spleen or liver. However, viral titres in the liver correlated well with ALT levels (CBA mice, pseudo-R 2 50.69, P,0.00005; BALB/c mice, partial-R 2 50.71; P,0.00005).
Viral persistence
As we noted no overt within-host interactions between the viral strains and no evidence of enhanced disease in multistrain-infected mice, we assessed the capacity of multistrain infection to prolong viral persistence. We used an uneven mix of three of the four C4 strains of MCMV in CBA and BALB/c mice (2.5610 3 p.f.u. C4A and C4B; 5610 3 p.f.u. C4C). Our rationale was that natural infections are unlikely to be initiated by equal doses of the infecting strains. We wished to also determine if a single of C4A, C4B, C4C or C4D individually, or 2.5¾10 3 p.f.u. of each virus as part of a mixed infection. Genome copies (Load) of the individual viral strains were assessed in singleand multi-strain-infected mice in (a) spleen 3 days p.i., (b) liver 3 days p.i. and (c) salivary glands 18 days p.i. Statistical analysis was performed as described in Methods, *P,0.05, **P,0.01, n55 mice per group. The x-axis is set at the limit of detection.
strain that comprised half the initial inoculum would, over time, become the dominant strain. In order to accommodate this and to maintain the inoculum sizes of the other two strains, we chose to exclude C4D as a large part of its genome was acquired via natural recombination with C4C . As seen in previous multi-strain infections, we saw no enhancement of viral load in spleen or liver of acutely infected BALB/c or CBA mice (data not shown).
In single-strain-infected CBA mice, all three strains of MCMV persisted in the salivary glands for 90 days p.i. (Fig.  6) , whilst in BALB/c mice the replicating virus was mostly cleared by this stage of infection (Fig. 7) . Therefore, independent of viral genetics, CBA mice supported viral replication longer than BALB/c mice. Importantly, multistrain infection did not enhance viral persistence -all three strains of virus co-replicated in CBA and BALB/c mice for periods consistent with their replication in single-straininfected mice. Strain distribution within the multiply infected CBA and BALB/c mice (Figs 6 and 7) indicated no obvious competitive or complementary interactions between the viruses. C4C did not gain an obvious benefit from comprising 50 % of the initial inoculum. However, more comprehensive studies would be warranted to explore the effects of inoculum composition. Finally, where subtle differences in the DNA copy load for individual MCMV strains in multi-strain-infected mice were noted, elevated replication was not at the expense of co-infecting strains.
DISCUSSION
This study had three main objectives. We sought to determine if competition, either apparent or resourcemediated, could be observed in strains of mice other than B6 mice; if complementation leading to enhanced viral loads was possible in multi-strain infection; and, finally, if in the absence of competition, viral strains were capable of long-term co-replication. To achieve this aim, we employed a mouse model of multi-strain MCMV infection using non-manipulated strains of virus isolated from a naturally acquired multi-strain infection. A previous study identified robust immune-mediated competition (also known as apparent competition) between strains of MCMV that lead to the preferential replication and shedding of more virulent viral strains in MCMV-resistant B6 mice (McWhorter et al., 2013) . This study extends those finding and demonstrates that competition is not the default outcome of multi-strain infection. In two different inbred strains of mice, we demonstrated that, in the absence of Ly49H, multiple strains of MCMV are able to co-exist for extended periods in the salivary gland -one of the major organs of transmission. This coexistence appears neutral for the virus (with little or no inhibition of viral replication or within-host competition) and for the host (with no enhancement of morbidity, viral load or viral clearance rates). Therefore, the outcome of multi-strain infection is dependent on the genetics of the host and the virus, and in the absence of strong selective pressure can lead to balanced co-existence of multiple viral strains.
Clinical studies have suggested a link between multi-strain HCMV infection and adverse clinical outcomes (Coaquette et al., 2004; Grundy et al., 1988; Humar et al., 2003; Ishibashi et al., 2007; Puchhammer-Stöckl et al., 2006; Sarcinella et al., 2002) . Enhanced disease in these patients could potentially be due to either complementation between viral strains leading to elevated viral replication or enhanced tissue damage, or could be due to competition leading to selection of more virulent strains. In this study, we found no evidence to support either conclusion. It is possible that such within-host interactions are more likely in the immunocompromised patients where enhanced disease has been demonstrated. Alternatively, occult competition or complementation may have occurred at time points or in tissues not assessed in this study. However, the data presented here best support a hypothesis that multiple infection can be neutral in mice.
Apparent competition is known to occur during multistrain MCMV infection. This competition is due to allelic Viral titres in the salivary glands of mice 18 days p.i. Statistical analysis was performed as described in Methods, *P,0.05, **P,0.01, n55 mice per group. The x-axis is set at the limit of detection.
variation within a single viral gene, m157. Preferential targeting of individual viral strains by NK-cells leads to selective shedding of more virulent MCMV strains (McWhorter et al., 2013) . Neither BALB/c nor CBA mice express Ly49H (Carlyle et al., 2008) , but they do vary in their capacity to control individual MCMV strains (Smith et al., 2008) . Whilst there were subtle differences in host resistance to the individual strains of MCMV used in this study, these differences were not significant. Therefore, the C4 strains of MCMV appear to have encountered broadly similar levels of immunosurveillance within CBA and BALB/ c mice. Failure to detect apparent competition supports this supposition and suggests that if differential recognition of individual strains did occur in CBA or BALB/c mice, this was too subtle to drive measurable competition. The exact 'strength' of strain-specific recognition required to mediate apparent competition is unknown. It remains possible that only the m157/Ly49H axis provides sufficient selective pressure to drive within-host competition between MCMV strains.
Other than apparent competition, co-infecting pathogen strains can also engage in resource competition, ultimately driving within-host interactions between strains of MCMV.
Resource competition occurs when pathogen strains compete for limited resources, such as seen during multistrain malaria infection and the competition for red blood cells (Balmer & Tanner, 2011) . It was possible that in our previous study the strong NK-cell-mediated apparent competition masked other forms of competition, in particular resource competition. This study suggests that infection. Genome copies (Load) of the individual viral strains were assessed in single-and multi-strain-infected mice in the (a) spleen 3 days p.i., (b) liver 3 days p.i. and (c) salivary glands 18 days p.i. Statistical analysis was performed as described in Methods, *P,0.05, **P,0.01, n55 mice per group. The x-axis is set at the limit of detection.
either the strains of MCMV do not occupy the same niche as each other or MCMV does not use host resources at a level sufficient to engender competition. Compartmentalization of variant strains of HCMV has been demonstrated in humans (reviewed by Renzette et al., 2014) . However, we saw no evidence of tissue-level compartmentalization in this study. Furthermore, it is known that MCMV strains can infect the same cells, as shown by empirical studies (Cicin-Sain et al., 2005) , and imputed from the evidence of extensive recombination within the genomes of both HCMV and MCMV (Faure-Della Corte et al., 2010; Smith et al., 2013) . Consequently, we support the latter hypothesis, and suggest that the low-level virulence, slow replication rate and relatively low titre in affected organs explains the lack of resource competition seen in this study. This lack of competition may help to explain why frequent multi-strain infection does not appear to have driven these viruses to become highly virulent.
Multi-strain MCMV infection did not alter host morbidity nor did it affect the rate at which the virus was cleared from the salivary gland. For the virus, multi-strain infection permits equivalent replication of all co-infecting strains, normal dissemination to the salivary gland and unchanged persistence. However, infections of both mice and humans with multiple strains of CMV is very common, suggesting some benefit to the virus. However, multi-strain infection could simply be a consequence of the CMV life style. That is, life-long infection means that CMV species do not induce sterilizing immunity in their respective hosts. Therefore, multi-strain infections will always arise as a consequence of reinfection. If this were the case, then evolution toward neutral co-infection may be the best strategy for viruses such as CMV. This would permit, essentially cost-free, maintenance of a large and genetically diverse pan-genome. This large pan-genome coupled with frequent co-infection would also provide a means for the rapid exchange of genetic material. MCMV encodes at least 22 genes that exist as series of conserved genotypes or alleles . These alleles are fixed by purifying selection , suggesting that any exchanged genes would be preselected for function. Recombination would allow for the exchange of alleles between viral strains and provide a mechanism for rapid responses to changes in the genetics of the host, such as may occur from immigration. Future studies will be directed toward determining the rate of recombination during multi-strain infection, if selection of recombinants can be linked to evasion of host immune responses and, finally, if recombination can enhance viral virulence, as has been demonstrated for HSV (Javier et al., 1986 ).
In conclusion, we have shown prolonged co-replication of MCMV strains in the salivary glands of mice. This continued co-replication would provide an opportunity for multistrain transmission of virus to the next host. Moreover, prolonged co-replication provides extended opportunities for recombination between strains of MCMV. This coreplication appears to occur without overt cost to the host or the virus. 
METHODS
Mice. Inbred female BALB/cArc (BALB/c) and CBA/CaHArc (CBA) mice were obtained from the Animal Resource Centre (Perth, Western Australia, Australia). All mice were infected at 6-8 weeks of age, and were maintained under specific-pathogen free conditions prior to and during experimentation. Animal experiments were performed with the approval of the Animal Ethics and Experimentation Committee of the University of Western Australia in accordance with the guidelines of the National Health and Medical Research Council.
Virus strains. The MCMV strains C4A, C4B, C4C and C4D were isolated from a single mouse (Mus musculus domesticus) collected from a location near Canberra (Australian Capital Territory, Australia), and have been previously described (Gorman et al., 2006; Smith et al., 2008) . The replication of C4A has been assessed in several mouse strains (Smith et al., 2008) , but the in vivo replication of all four strains has only been assessed in C57BL/6 mice (McWhorter et al., 2013) . All the viral isolates used in these studies were genetically distinct as determined by whole-genome sequencing (Smith et al., 2008 ('Multi'). Genome copies of the individual viral strains were assessed in the salivary glands of single-and multi-strain-infected mice at (a) 18, (b) 30, (c) 45 and (d) 90 days p.i. Statistical analysis was performed as described in Methods, *P,0.05, **P,0.01, n55 mice per group. The x-axis is set at the limit of detection.
Viruses were propagated in vitro in BALB/c mouse embryonic fibroblasts and were maintained as low passage stocks.
All in vivo experiments were performed with secondary salivarygland-derived virus stocks. These stocks were raised by two passages in weanling female CBA or BALB/c mice. Control, single-straininfected mice were inoculated with 1610 4 p.f.u. virus via the intraperitoneal route. Multi-strain infections were also given via the intraperitoneal route and in most experiments comprised a mixed inoculum of up to four different strains of MCMV, with each strain being an equal fraction of the total 1610 4 p.f.u. inoculum. In some experiments an uneven mix of virus was used, although the total viral inoculum remained the same.
Virus determination in vivo. Viral titres in mice were determined by standard plaque assay (Scalzo et al., 1990) . Briefly, organs were homogenized at 0.1 mg ml 21 in 16 minimal essential medium (MEM)/ 2 % newborn calf serum (NCS) using a TissueLyser II (Qiagen) at 25 Hz for 2.5 min. Duplicate dilutions of clarified homogenates were added to confluent monolayers of mouse embryonic fibroblasts and C4C ('Multi'). Genome copies of the individual viral strains were assessed in the salivary glands of single-and multi-straininfected mice at (a) 18, (b) 30, (c) 45 and (d) 90 days p.i. Statistical analysis was performed as described in Methods, *P,0.05, **P,0.01, n55 mice per group. The x-axis is set at the limit of detection.
incubated for 1 h at 37 uC. Following removal of homogenates, the cells were overlaid with 1 ml methylcellulose/MEM/2 % NCS. Plaque assays were stopped after 5 days by the addition of methylene blue stain containing 4 % formaldehyde. All titres were expressed as p.f.u.
(g tissue) -1 .
Multiplex qRT-PCR assay. DNA was extracted from amounts of organ homogenate equivalent to 10 mg using a Wizard Genomic DNA kit (Promega) according to the manufacturer's specifications. DNA was quantified spectrophotometrically in UV transparent 96-well microtitre plates (Costar) on a POLARstar Omega microplate reader (BMG Labtech).
In order to determine PCR sensitivity and generate standard curves for the qRT-PCR, plasmids were constructed containing the m144 gene from each C4 MCMV strain. Gateway Technology (Invitrogen) was used to clone a region of m144 (202 900-203 380 according to the published C4A strain sequence; GenBank accession number EU579861) into the pDONR201 vector (Invitrogen). The target region of m144 was PCR-amplified from each viral strain using PCR primers with 59 attB sites and the high-fidelity Phusion enzyme (Finnzymes; Thermo-Fisher Scientific). The PCR product was then cloned into the pDONR201 vector (Invitrogen) using a BP recombination reaction. Insertion and gene sequences were confirmed by sequence analysis.
A single forward (59-ACAGGACGACCGAGTTCCCCG-39) and reverse (59-GTTGYACATCTAAGATCGAGAAACA-39) primer pair (GeneWorks) was designed to amplify a region of the MCMV gene, m144. The primer binding sites are conserved in all C4 strains. MCMV strain-specific oligonucleotide probes were designed by TIB Molbiol. Probes had a 59 fluorophore attached to a strain-specific oligonucleotide sequence followed by a 39 quench (Blackhole Quench, BHQ-1). Probe sequences were: C4A (FAM-ATTCGAACCTGTTCACTGGCG-BHQ1), C4B (HEX-CTTAGCTTCTTTTGACAGTCACGGTC-BHQ1) (GeneWorks), C4C (LC610-CAAAGCGGCGCAGCAACATAAC-BHQ1) and C4D (LC670-TCCAAACCCCAAACCAAAACCACGC-BHQ1) (SigmaAldrich). The specificity of each MCMV probe was confirmed by testing their cross-reactivity with other virus strains. Minor crossreactivity between the probes used to detect strains C4B and C4C were removed by colour compensation and use of fit-points quantification.
The PCR mix comprised 10 ml Roche 26 Probes Master Mix and 500 nm primers. Optimal probe concentrations were 250 nM for the C4A (FAM), C4C (LC610) and C4D (LC670) probes, and 375 nM for the C4B (HEX) probe. A total of 100 ng genomic DNA was added to each reaction mix. Cycling conditions were: 10 min 95 uC, followed by 45 cycles each consisting of 30 s at 95 uC and 2.0 min at 66 uC, and a final cooling step to 50 uC for 10 s. Concentrations of viral DNA were calculated relative to an internal standard control using fitpoints analysis (LightCycler 480 software). The dynamic range of the four different PCR targets was confirmed over a range of plasmid dilutions from 10 9 to 10 1 with correlation coefficients of 0.9970 for C4A, 0.9970 for C4B, 0.9985 for C4C and 0.9982 for C4D.
Genome load [copy number (g tissue) 21 ] was plotted against viral titre [p.f.u. (g tissue) 21 ] for the spleen, liver and salivary glands in infected mice (Fig. S1A , available in the online Supplementary Material). Spearman's rank correlation was then performed to analyse the relationship between genome copy number and replicating virus in each tissue. The correlation coefficients for DNA/infectious virus were: spleen (rs50.76, P,0.001), liver (rs50.65, P,0.001) and salivary glands (rs50.93, P,0.001) (Fig. S1B ). In the spleen and liver, the genomes : infectious virus (p.f.u.) ratios were 300 : 1 and 400 : 1, respectively (Fig. S1C) . In the salivary glands, the ratio was significantly (P,0.0001) different at 30 : 1 (Fig. S1C) . These ratios were consistent across all MCMV strains.
Statistics. Kruskal-Wallis one-way ANOVA with post hoc analysis utilizing Dunn's multiple comparisons test was used to determine statistical significance in single-strain-infected mice. The repeated measures Friedman test with Dunn's post hoc analysis was employed to determine statistical significance in multi-strain-infected mice. A Spearman rank correlation coefficient was used to determine the relationship between infectious virus and viral DNA as determined by the MCMV strain-specific multiplex qRT-PCR assay. All statistical analyses were performed using Prism 5.0 (GraphPad).
